Rapid Micro Biosystems (RPID) Operating Margin (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Operating Margin of 173.11% for Q1 2026, down 59.94% sequentially from 108.23% in Q4 2025, and down 1126.0% YoY from 16.87% in Q1 2025.
Rapid Micro Biosystems (RPID) Operating Margin (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Operating Margin for 7 years, with the latest figure at 173.11% in Q1 2026.
- Quarterly Operating Margin fell 1126.0% year-over-year to 173.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 144.2% (up 1537.0% YoY) and the FY2025 annual result came in at 141.1%, up 3686.0% from the prior year.
- Operating Margin retreated to 173.11% in Q1 2026 per RPID's latest filing, from 108.23% in the prior quarter.
- Over five years, Operating Margin peaked at 108.23% in Q4 2025 and troughed at 394.6% in Q4 2022.
- A 5-year average of 234.99% and a median of 202.15% in 2024 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2022 and 2023: Operating Margin slumped 18742 bps in 2022, then jumped 20227 bps in 2023.
- Over 5 years, Operating Margin stood at 394.6% in 2022, then jumped by 51 bps to 192.33% in 2023, then jumped by 35 bps to 124.47% in 2024, then rose by 13 bps to 108.23% in 2025, then slumped by 60 bps to 173.11% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 173.11%, 108.23%, and 145.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.55 Bn | 196.95 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 126.43 Bn | 122.95 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 74.11 Bn | 73.57 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.70 Bn | 47.44 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 35.04 Bn | 33.10 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 19.15% |
| 10 | Rapid Micro Biosystems | 79.05 Mn | 59.28 Mn | 1.21 Mn | -152.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -152.99% |
| Mar 31, 2026 | -173.11% |
| Dec 31, 2025 | -108.23% |
| Sep 30, 2025 | -145.09% |
| Jun 30, 2025 | -167.28% |
| Mar 31, 2025 | -161.85% |
| Dec 31, 2024 | -124.47% |
| Sep 30, 2024 | -158.32% |
| Jun 30, 2024 | -202.15% |
| Mar 31, 2024 | -254.38% |
| Dec 31, 2023 | -192.33% |
| Sep 30, 2023 | -235.13% |
| Jun 30, 2023 | -300.96% |
| Mar 31, 2023 | -295.37% |
| Dec 31, 2022 | -394.60% |
| Sep 30, 2022 | -356.32% |
| Jun 30, 2022 | -364.61% |
| Mar 31, 2022 | -360.55% |
| Dec 31, 2021 | -279.49% |
| Sep 30, 2021 | -175.72% |